89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
Current price | $7.98 | 52-week high | $16.63 |
Prev. close | $7.99 | 52-week low | $7.00 |
Day low | $7.68 | Volume | 674,800 |
Day high | $8.07 | Avg. volume | 957,560 |
50-day MA | $8.17 | Dividend yield | N/A |
200-day MA | $9.07 | Market Cap | 846.89M |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
1-mo | -1.72% |
3-mo | -9.88% |
6-mo | -1.97% |
1-year | 5.00% |
3-year | -47.26% |
5-year | -73.34% |
YTD | -28.56% |
2023 | -12.25% |
2022 | -2.60% |
2021 | -46.37% |
2020 | -7.30% |
2019 | N/A |
Loading social stream, please wait...